Costas Papadopoulos winner of eScience Center - Lorentz Competition
Costas Papdopoulos is the winner of the eScience Center - Lorentz Competition. With a grant of €50,000 that this competition provides, Costas will be able to organise a 5-day workshop with 25 international experts on 3D heritage from the academic community and the public/private sector to explore 'Paradata in 3D Scholarship: Intellectual Transparency and Scholarly Argumentation in Digital Heritage'.
The workshop emphasises international collaboration, with participants from various countries, including Portugal, Sweden, the United States, Germany, Cyprus, Ireland, the United Kingdom, and the Netherlands. This international participation ensures that the workshop's outcomes are globally relevant and can be applied across different cultural and institutional contexts. This is amplified by the involvement of major institutions, such as The Smithsonian and the Victoria & Albert Museum, and organisations, such as CIDOC, the Time Machine, and Europeana. The workshop also includes a significant representation from the Dutch research Community, including institutions such as the University of Amsterdam, Leiden University, Beeld & Geluid, DANS, and Erfgoed Leiden en Omstreken.
The grant also provides 400 hours of research software engineering through the eScience Centre to extend the national research infrastructure, PURE3D, that Costas leads, by developing systems and workflows for the documentation of paradata* for 3D heritage projects.
*paradata: documentation of the decision making process in digitising/reconstructing cultural heritage
Also read
-
It probably hasn't escaped your attention that we are dealing with a disruption in our network. At the moment, the network varies from working just fine to being really slow or going down completely. The disruption has an external cause and is targeting the shared SURF servers of educational institutions. UM is therefore not the only institution experiencing problems.
-
Maastricht University (UM) will support the Université de Burundi with the development of educational programs in IT.
-
Obesity is one of the great public health problems we face. New drugs such as Ozempic offer possibilities but also raise moral, economic and health questions. Why is ‘just lose some weight’ naïve and unempirical? Why might covering Ozempic be cheaper for health insurers? We brought together experts Anne Roefs, Gijs Goossens and Mickaël Hiligsmann to talk about obesity and its new miracle cure.
